P Albers

Summary

Affiliation: Heinrich Heine University
Country: Germany

Publications

  1. doi request reprint EAU guidelines on testicular cancer: 2011 update
    Peter Albers
    Department of Urology, Düsseldorf University, Dusseldorf, Germany
    Eur Urol 60:304-19. 2011
  2. doi request reprint [The future of uro-oncology: what needs to be done to secure its place in the field of urology?]
    P Albers
    Urologische Klinik, Universitatsklinikum Dusseldorf, Moorenstraße 5, 40225 Dusseldorf, Deutschland
    Urologe A 50:914-6. 2011
  3. doi request reprint [Chemotherapy for urothelial cancer of the bladder--update 2012]
    G Niegisch
    Medizinische Fakultat, Urologische Klinik, Heinrich Heine Universitat, Dusseldorf, Germany
    Aktuelle Urol 43:412-9. 2012
  4. doi request reprint [Robot-assisted radical cystectomy: do we actually need a robot?]
    G Niegisch
    Urologische Klinik, Heinrich Heine Universitat Dusseldorf, Moorenstraße 5, 40625 Düsseldorf, Deutschland
    Urologe A 51:319-24. 2012
  5. doi request reprint [Quality control in the implementation of new surgical procedures: Da Vinci robot-assisted systems]
    G Niegisch
    Urologische Klinik, Medizinische Fakultat, Heinrich Heine Universitat, Moorenstraße 5, 40225, Dusseldorf, Deutschland
    Urologe A 50:1288-90. 2011
  6. ncbi request reprint Risk factors for relapse in stage I non-seminomatous germ-cell tumors: preliminary results of the German Multicenter Trial. German Testicular Cancer Study Group
    P Albers
    Department of Urology, Bonn University, Germany
    Int J Cancer 83:828-30. 1999
  7. doi request reprint Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard
    L Schimmöller
    Medical Faculty, Department of Diagnostic and Interventional Radiology, University Düsseldorf, Moorenstr 5, 40225, Dusseldorf, Germany
    Eur Radiol 23:3185-90. 2013
  8. ncbi request reprint Adjuvant chemotherapy in stage I and stage II testicular cancer
    P Albers
    Department of Urology, Bonn University, 53105 Bonn, Germany
    World J Urol 19:76-81. 2001
  9. ncbi request reprint Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR
    P Albers
    Department of Urology, Bonn University, Germany
    Anticancer Res 20:2107-11. 2000
  10. doi request reprint [Retroperitoneal lymphadenectomy - pro robotic]
    P Albers
    Klinik für Urologie, Universitatsklinikum, Heinrich Heine Universitat Dusseldorf, Moorenstraße 5, 40225 Dusseldorf, Deutschland
    Urologe A 51:687-91. 2012

Detail Information

Publications22

  1. doi request reprint EAU guidelines on testicular cancer: 2011 update
    Peter Albers
    Department of Urology, Düsseldorf University, Dusseldorf, Germany
    Eur Urol 60:304-19. 2011
    ..On behalf of the European Association of Urology (EAU), guidelines for the diagnosis, therapy, and follow-up of testicular cancer were established...
  2. doi request reprint [The future of uro-oncology: what needs to be done to secure its place in the field of urology?]
    P Albers
    Urologische Klinik, Universitatsklinikum Dusseldorf, Moorenstraße 5, 40225 Dusseldorf, Deutschland
    Urologe A 50:914-6. 2011
    ..Thus, clinical centers for uro-oncology must include specialists in pharmacological therapy for cancer and drug development who will work closely with the department of urology...
  3. doi request reprint [Chemotherapy for urothelial cancer of the bladder--update 2012]
    G Niegisch
    Medizinische Fakultat, Urologische Klinik, Heinrich Heine Universitat, Dusseldorf, Germany
    Aktuelle Urol 43:412-9. 2012
    ..This review discusses the current standards and developments in the chemotherapeutic treatment of urothelial bladder cancer. Furthermore, it should provide a framework for reasonable treatment choices in daily clinical practice...
  4. doi request reprint [Robot-assisted radical cystectomy: do we actually need a robot?]
    G Niegisch
    Urologische Klinik, Heinrich Heine Universitat Dusseldorf, Moorenstraße 5, 40625 Düsseldorf, Deutschland
    Urologe A 51:319-24. 2012
    ..However, whether patients or patient subgroups truly benefit from robot-assisted cystectomy needs to be elucidated in the future...
  5. doi request reprint [Quality control in the implementation of new surgical procedures: Da Vinci robot-assisted systems]
    G Niegisch
    Urologische Klinik, Medizinische Fakultat, Heinrich Heine Universitat, Moorenstraße 5, 40225, Dusseldorf, Deutschland
    Urologe A 50:1288-90. 2011
    ..Only by using these measures will it be possible to compare robot-assisted procedures of different institutions and historical data of conventional surgery with regard to oncological and functional efficacy...
  6. ncbi request reprint Risk factors for relapse in stage I non-seminomatous germ-cell tumors: preliminary results of the German Multicenter Trial. German Testicular Cancer Study Group
    P Albers
    Department of Urology, Bonn University, Germany
    Int J Cancer 83:828-30. 1999
    ..The preliminary results of the current German Multicenter Trial suggest an inferior value of prediction for low-risk patients if risk factor analysis and/or CT staging is performed in non-specialized centers...
  7. doi request reprint Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard
    L Schimmöller
    Medical Faculty, Department of Diagnostic and Interventional Radiology, University Düsseldorf, Moorenstr 5, 40225, Dusseldorf, Germany
    Eur Radiol 23:3185-90. 2013
    ..The aim of this study was to investigate the inter-reader agreement of this scoring system...
  8. ncbi request reprint Adjuvant chemotherapy in stage I and stage II testicular cancer
    P Albers
    Department of Urology, Bonn University, 53105 Bonn, Germany
    World J Urol 19:76-81. 2001
    ..Thus, 50-84% of patients receive adjuvant treatment unnecessarily. Prognostic factors have been developed in each tumor entity to tailor treatment to patients with high risk of recurrence...
  9. ncbi request reprint Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR
    P Albers
    Department of Urology, Bonn University, Germany
    Anticancer Res 20:2107-11. 2000
    ....
  10. doi request reprint [Retroperitoneal lymphadenectomy - pro robotic]
    P Albers
    Klinik für Urologie, Universitatsklinikum, Heinrich Heine Universitat Dusseldorf, Moorenstraße 5, 40225 Dusseldorf, Deutschland
    Urologe A 51:687-91. 2012
    ..Only patients with relatively small residual tumors without a major involvement of great vessels can be considered as candidates for robotic-assisted post-chemotherapy RPLND...
  11. doi request reprint [Value of galvanotherapy for localised prostate cancer]
    C Arsov
    Klinik für Urologie, Heinrich Heine Universitat, Moorenstrasse 5, 40225 Dusseldorf
    Urologe A 48:748-54. 2009
    ..For this procedure well-designed clinical trials and a longer follow-up are mandatory to assess the true role of electrotherapy in the management of prostate cancer...
  12. doi request reprint Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients
    D Barski
    Department of Urology, Duesseldorf University Hospital, Moorenstrasse 5, 40225, Dusseldorf, Germany
    World J Urol 31:1253-9. 2013
    ....
  13. doi request reprint [Robot-assisted radical cystectomy. Pilot study for the prospective evaluation of perioperative parameters compared to open radical cystectomy]
    G Niegisch
    Urologische Klinik, Heinrich Heine Universitat, Universitatsklinikum Dusseldorf, Moorenstraße 5, 40225, Dusseldorf, Deutschland
    Urologe A 50:1076-82. 2011
    ..This pilot study evaluated which parameters should be assessed and which problems might occur for assembly and interpretation of data...
  14. ncbi request reprint Erythropoietin in urologic oncology
    P Albers
    Department of Urology, Universitat Bonn, Germany
    Eur Urol 39:1-8. 2001
    ..Only with a substantial risk for blood transfusion is substitution treatment by EPO justified. Additionally, the long-term risks of blood transfusions have to be balanced against the costs of EPO treatment...
  15. doi request reprint [Standardised scoring of a multi-parametric 3-T MRI for a targeted MRI-guided prostate biopsy]
    C Arsov
    Klinik für Urologie, Universitatsklinikum Dusseldorf, Dusseldorf
    Urologe A 51:848-56. 2012
    ..This is a pilot study to evaluate the consensus-based international MRI scoring system as decision criterion for targeted MRI-guided prostate biopsy...
  16. doi request reprint [Signal transduction in urothelial cancer: how exactly do we know the targets for targeted therapy?]
    G Niegisch
    Urologische Klinik, Medizinische Fakultat, Heinrich Heine Universitat, Moorenstraße 5, 40625 Düsseldorf, Deutschland
    Urologe A 49:1401-5. 2010
    ..Target genes of cancer pathways are regulated by epigenetic mechanisms, which determine their inducibility. Elucidating these control mechanisms could therefore prove important for developing targeted therapies for urothelial carcinoma...
  17. ncbi request reprint [Interdisciplinary recommendations on targeted therapy in the treatment of renal cell carcinoma]
    K Miller
    Urologische Klinik, Charite Berlin, Germany
    Aktuelle Urol 38:328-30. 2007
    ..This has raised both new opportunities and new questions for the health care professionals involved. Here we report on a consensus conference addressing these questions with answers based on evidence from the recent literature...
  18. ncbi request reprint Long term results and morbidity of paraaortic compared with paraaortic and iliac adjuvant radiation in clinical stage I seminoma
    D Melchior
    Department of Urology, Bonn University, Germany
    Anticancer Res 21:2989-93. 2001
    ..Radiotherapy is accepted as standard adjuvant treatment for low-stage seminoma and results in excellent survival rates. The optimal radiation field for stage I seminoma, however, is still being discussed. Patients and..
  19. doi request reprint [Update on first-line and relapse chemotherapy for testicular cancer]
    A Lorch
    Bereich Konservative Urologische Onkologie, Klinik für Urologie, Universitatsklinikum Dusseldorf, Moorenstraße 5, 40255, Dusseldorf, Deutschland
    Urologe A 52:1547-8, 1550-5. 2013
    ..It also results in lower cure rates with the need for further therapy or leads to death of the patient without ever having had a chance for cure...
  20. ncbi request reprint Organ sparing surgery for malignant germ cell tumor of the testis
    A Heidenreich
    Department of Urology, Philipps-University Marburg, Marburg, Krankenhaus Am Urban, Berlin, Germany
    J Urol 166:2161-5. 2001
    ..multiple biopsies of the tumor bed, adjuvant local irradiation postoperatively to avoid local recurrence, close followup and high compliance...
  21. doi request reprint [Seminal vesicle sparing radical perineal prostatectomy]
    S Schafers
    Klinik für Urologie, Universitatskliniken, Moorenstrasse 5, 40255, Dusseldorf, Deutschland
    Urologe A 48:408-14. 2009
    ..The early and mid-term oncological and functional results of a seminal vesicle sparing modification of perineal nerve sparing radical prostatectomy (SV-RPP) was compared to the classical perineal (RPP) and retroperitoneal (RRP) approaches...
  22. ncbi request reprint [Therapeutic options for hormone-refractory prostate cancer]
    K Miller
    Urologische Klinik, Charite, Campus Benjamin Franklin, Universitatsmedizin, Hindenburgdamm 30, 12200, Berlin, Germany
    Urologe A 45:580, 582-5. 2006
    ..Side effects include flu-like symptoms, muscle pain, and edemas. Zoledronic acid also belongs to the standard treatment of hormone-refractory prostate cancer with bone metastases...